<VariationArchive VariationID="870377" VariationName="NM_014140.4(SMARCAL1):c.250dup (p.Gln84fs)" VariationType="Duplication" Accession="VCV000870377" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-19" DateCreated="2020-05-04" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="858547" VariationID="870377">
      <GeneList>
        <Gene Symbol="SMARCAL1" FullName="SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1" GeneID="50485" HGNC_ID="HGNC:11102" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q35</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="216412484" stop="216483053" display_start="216412484" display_stop="216483053" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="217277136" stop="217347775" display_start="217277136" display_stop="217347775" Strand="+" />
          </Location>
          <OMIM>606622</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014140.4(SMARCAL1):c.250dup (p.Gln84fs)</Name>
      <CanonicalSPDI>NC_000002.12:216414952:CC:CCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q35</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="216414952" stop="216414953" display_start="216414952" display_stop="216414953" variantLength="1" positionVCF="216414952" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="217279675" stop="217279676" display_start="217279675" display_stop="217279676" variantLength="1" positionVCF="217279675" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
      </Location>
      <ProteinChange>Q84fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.217279677dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.217279677dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.216414954dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.216414954dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009771.1" sequenceAccession="NG_009771" sequenceVersion="1" change="g.7541dup">
            <Expression>NG_009771.1:g.7541dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127207.2" sequenceAccession="NM_001127207" sequenceVersion="2" change="c.250dup">
            <Expression>NM_001127207.2:c.250dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120679.1" sequenceAccession="NP_001120679" sequenceVersion="1" change="p.Gln84fs">
            <Expression>NP_001120679.1:p.Gln84fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014140.4" sequenceAccession="NM_014140" sequenceVersion="4" change="c.250dup" MANESelect="true">
            <Expression>NM_014140.4:c.250dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_054859.2" sequenceAccession="NP_054859" sequenceVersion="2" change="p.Gln84fs">
            <Expression>NP_054859.2:p.Gln84fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_108" sequenceAccession="LRG_108">
            <Expression>LRG_108:g.7541dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_108t1" sequenceAccession="LRG_108t1">
            <Expression>LRG_108t1:c.250dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014140.3" sequenceAccession="NM_014140" sequenceVersion="3" change="c.250dupC">
            <Expression>NM_014140.3:c.250dupC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1693554666" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014140.4(SMARCAL1):c.250dup (p.Gln84fs) AND Schimke immuno-osseous dysplasia" Accession="RCV001089943" Version="6">
        <ClassifiedConditionList TraitSetID="1147">
          <ClassifiedCondition DB="MedGen" ID="C0877024">Schimke immuno-osseous dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-02-02" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-02" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-05-04" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11799392</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301550</ID>
          <ID Source="BookShelf">NBK1376</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-24">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-03-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1147" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5333" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spondyloepiphyseal dysplasia nephrotic syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Schimke immunoosseous dysplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Schimke immuno-osseous dysplasia</ElementValue>
                <XRef ID="MONDO:0009458" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SIOD</ElementValue>
                <XRef Type="MIM" ID="242900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Schimke immunoosseous dysplasia (SIOD) is characterized by spondyloepiphyseal dysplasia (SED) resulting in short stature, nephropathy, and T-cell deficiency. Radiographic manifestations of SED include ovoid and mildly flattened vertebral bodies, small ilia with shallow dysplastic acetabular fossae, and small deformed capital femoral epiphyses. Nearly all affected individuals have progressive steroid-resistant nephropathy, usually developing within five years of the diagnosis of growth failure and terminating with end-stage renal disease. The majority of tested individuals have T-cell deficiency and an associated risk for opportunistic infection, a common cause of death. SIOD involves a spectrum that ranges from an infantile or severe early-onset form with a greater risk of death during childhood to a juvenile or milder later-onset form with likely survival into adulthood if renal disease is appropriately treated.</Attribute>
                <XRef ID="NBK1376" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4984" />
                <XRef ID="4984" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301550</ID>
                <ID Source="BookShelf">NBK1376</ID>
              </Citation>
              <XRef ID="1830" DB="Orphanet" />
              <XRef ID="C0877024" DB="MedGen" />
              <XRef ID="MONDO:0009458" DB="MONDO" />
              <XRef Type="MIM" ID="242900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2466144" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2020-05-04">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_014140_3_SMARCAL1_c_250dupC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001244988" DateUpdated="2022-12-24" DateCreated="2020-05-04" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Schimke immunoosseous dysplasia (MIM#242900). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. Other variants predicted to cause NMD have been reported in ClinVar as pathogenic in individuals with Schimke immunoosseous dysplasia. (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1205 - This variant has been shown to be maternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMARCAL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_12687</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014140.3:c.250dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="242900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6379721</SubmissionName>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4219047" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="15059599|MedGen:C0877024" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002197796" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11799392</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301550</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gln84Profs*5) in the SMARCAL1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMARCAL1 are known to be pathogenic (PMID: 11799392, 20301550). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 870377). This variant has not been reported in the literature in individuals affected with SMARCAL1-related conditions.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMARCAL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.217279675_217279676insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0877024" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4219047" TraitType="Disease" MappingType="XRef" MappingValue="C0877024" MappingRef="MedGen">
        <MedGen CUI="C0877024" Name="Schimke immuno-osseous dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2466144" TraitType="Disease" MappingType="XRef" MappingValue="242900" MappingRef="OMIM">
        <MedGen CUI="C0877024" Name="Schimke immuno-osseous dysplasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

